Home › Cardiovascular Disease › Michigan › Lansing
Cardiovascular Disease clinical trials in Lansing, MI
3 studies for Cardiovascular Disease are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Lansing
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- McLaren Center for Research and Innovation, Lansing
- UMH-Sparrow Clinical Research Institute, Lansing
Product Surveillance Registry
RecruitingObservational study
- Lansing, Lansing
Cardiovascular Disease trials in other cities
- Boston, MA34 studies
- New York City, NY30 studies
- Washington, DC27 studies
- Dallas, TX24 studies
- Houston, TX22 studies
- Philadelphia, PA22 studies
- Pittsburgh, PA21 studies
- St. Louis, MO20 studies
- Cleveland, OH20 studies
- San Francisco, CA20 studies
- Chicago, IL20 studies
- Atlanta, GA20 studies
Other studies in Lansing
- Lung Cancer12 studies
- Prostate Cancer10 studies
- Non-Small Cell Lung Cancer10 studies
- Breast Cancer10 studies
- Cancer (all types)6 studies
- Disorders of Excessive Somnolence6 studies
- Sleep Disorders5 studies
- Bladder Cancer5 studies
- Laryngeal Cancer5 studies
- Ovarian Cancer4 studies
- Multiple Myeloma4 studies
- Narcolepsy4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.